58 Biggest Movers From Friday
Gainers
Hagerty, Inc. (NYSE: HGTY) shares jumped 46.5% to close at $15.62.
TuanChe Limited (NASDAQ: TC) gained 44.7% to settle at $3.30.
Mid-Afternoon Market Update: DocuSign Drops Following Weak Revenue Forecast; Longeveron Shares Climb
Toward the end of trading Friday, the Dow traded down 0.37% to 34,512.05 while the NASDAQ fell 2.28% to 15,029.99. The S&P also fell, dropping 1.13% to 4,525.40.
Mid-Day Market Update: Nasdaq Dips Over 400 Points; Marvell Technology Shares Rise Following Upbeat Earnings
Midway through trading Friday, the Dow traded down 0.77% to 34,373.98 while the NASDAQ fell 2.8% to 14,950.19. The S&P also fell, dropping 1.52% to 4,507.37.
41 Stocks Moving In Friday’s Mid-Day Session
Gainers
IO Biotech, Inc. (NASDAQ: IOBT) jumped 42% to $11.74. The company, last month, priced its IPO at $14 per share.
Mid-Morning Market Update: Markets Open Lower; Big Lots Issues Weak Profit Forecast
Following the market opening Friday, the Dow traded down 0.31% to 34,532.63 while the NASDAQ fell 1.44% to 15,160.41. The S&P also fell, dropping 0.60% to 4,549.65.
Celyad Oncology Shares Gain After Fortress Injects $32M Via Equity
Celyad Oncology SA (NASDAQ: CYAD) has announced a
HC Wainwright & Co. Maintains Buy on Celyad Oncology, Lowers Price Target to $15
HC Wainwright & Co. analyst Edward White maintains Celyad Oncology (NASDAQ:CYAD) with a Buy and lowers the price target from $17 to $15.
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
The Daily Biotech Pulse: Pfizer’s Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)